Top Tweets for #Padcev
Business Intelligence | Pfizer Reports $15.0 Billion Q2 2026 Revenue and Raises Full-Year Outlook
Full data analysis on BiotechReality:
https://t.co/nOmNN2khvz
#BusinessIntelligence #PharmaEarnings #Pfizer #Q22026 #BiotechReality #FinancialResults #Eliquis #Vyndaqel #Padcev
🆕 Recently approved by the FDA in #BladderCancer: When compared with chemotherapy, the combination of @Merck’s #Keytruda ➕ @AstellasUS’s #Padcev improved:
📈 Overall survival by 35%
📈 Event-free survival by 47% https://t.co/fwYm0qI4kq
❗ The #FDA approved @Merck’s #Keytruda ➕ @AstellasUS’s #Padcev for adults with muscle-invasive #BladderCancer.
The combination improved overall survival by 3️⃣5️⃣% compared with chemotherapy alone. https://t.co/1lt8BrS8rg
New research is exploring whether combining #Padcev and #Keytruda can improve outcomes in bladder #BladderCancer. 🔬
Here’s what patients should know about this approach: https://t.co/8DUNskAkdg
🎯 The @US_FDA granted fast track status to AVZO-103 for advanced #UrothelialCancer after #Padcev. This designation may help speed development and expand options for patients with urgent unmet needs. #BladderCancer #Oncology
Read more! https://t.co/DmmyptZ3gc
🎗️ Breakthrough in bladder cancer!
Pfizer’s #Padcev + Merck’s #Keytruda boosted survival in muscle-invasive cases when used before & after surgery vs surgery alone.
One step closer to changing the standard of care ✨
🔎 @Biopharmiq_B2B tracks 390+ trials from 100+ companies!
🚨 @FDA Approval Alert
Perioperative #KEYTRUDA® (pembrolizumab) + #PADCEV® (enfortumab vedotin-ejfv) receives FDA approval for cisplatin-ineligible MIBC before & after surgery.
@OncoAlert
@biospace @Merck
✍️ First systemic perioperative regimen to significantly improve EFS, OS & pCR vs surgery alone.
✅ Consistent safety profile
🔑 Expands curative-intent options for a population with high unmet need
#BladderCancer #FDAApproval #UrothelialCarcinoma #ImmunoOncology #MedicalWatch #GlobalGU
@Adium_Ecuador @adiummx
https://t.co/SJypcelPCa
Effets secondaires graves du nouveau traitement #Pfizer contre le cancer de la vessie #PADCEV plus pembrolizumab.
Des effets indésirables graves sont survenus chez 50% des patients traités par PADCEV en association avec le pembrolizumab.
Des effets indésirables mortels sont survenus chez 3,9% des patients.
https://t.co/LojwoVv0wT
#EuropeanCommission Greenlights #Keytruda and #Padcev Combo as First-Line Treatment for Advanced #UrothelialCarcinoma
https://t.co/iCUej4ecHN
#Nachrichten #Gesundheit #Gesundheitswesen #pharma #pharmaceutical #breaking #breakingnews #news #media #medicine #europe #OncoTwitter
💫🌟🚨 El boletín @OncoAlert ya está disponible 🚨🌟💫
📅 Cubre del 23 al 29 de agosto de 2024
📝 Regístrate en https://t.co/lbJtQ6FXbn o en https://t.co/iQscjUZYfA…
🌟 La Comisión Europea aprueba #PADCEV™ (enfortumab vedotin) en combinación con #KEYTRUDA® (pembrolizumab) como tratamiento de primera línea para el cáncer urotelial avanzado 🌟
🔹 Aprobación histórica: Esta combinación supera a la quimioterapia basada en platino tras 40 años como estándar.
🔹 Resultados clave: Duplica la supervivencia global mediana y reduce en un 55% el riesgo de progresión o muerte.
🔹 Un nuevo capítulo en la lucha contra esta enfermedad letal.
#Oncología #CáncerUrotelial #InnovaciónEnSalud
@OncoAlert @WorldBladderCan @BladderCaJrnl @BladderCancerUS
The @OncoAlert 🚨Newsletter NOW OUT
Covering August 23-29, 2024
Register at https://t.co/rs8wXnwI7i or https://t.co/hwvqbilbLO
Discussing:
✅EV302 leads to authorization in Europe🇪🇺
✅ESMO Tumour-Agnostic Classifier and Screener
✅Next-generation #LungCancer 🫁 pathology🔬
✅promises & challenges in treatment of adv #NSCLC
✅Renal Cell Carcinoma: A Review
✅Time From Colorectal Cancer Surgery to Adj Chemo
✅Cancer Survivors' Experience of Care & Financial Tox
✅Guide to large data sets for population-based cancer research out on @JournalCancer
✅Proteogenomics of #ProstateCancer Radioresistance☢️
✅Dose dense🆚3 weekly AC during neoadj chemoimmunotherapy for #TNBC #BreastCancer
✅Effect of complete transurethral resection on oncologic outcomes after RT☢️for #BladderCancer
@tompowles1 @BenWestphalen @VivekSubbiah @DrYukselUrun @scserendipity1 @acmoorephd @bmassutis @MEVidalSerodio @mayluciemeyer @drenriquegrande @RSanchez_Salas @RenoHemonc @rayychan @matteolambe @Icro_Meattini @DrRBarroso @kevinpunie @crisbergerot @VJOncology @mirrorsmed @high5md @JaniceTNBCmets @HenningWillers @PGrivasMDPhD @apolo_andrea
#OncoAlertAF
@nataliagandur @acampsmalea @BiagioRicciutMD
@yekeduz_emre @HHorinouchi @FadiHaddad_MD
@Dr_Ivanoncologo @Abdallah81MD @FernandoOnco
@ElisaAgostinett @to_be_elizabeth @lungoncdoc @bavilima @realbowtiedoc @Erman_Akkus @DrFMartinelli @Lucarecco @orellanauro
The MHLW Granted Priority Review to Astellas’ sNDA for Padcev and Keytruda as Combination Therapy to Treat Bladder Cancer
#astellaspharma #padcev #keytruda #bladdercancer #regulatory #priorityreview #mhlw #japan #merck #urothelialcancer #chemotherapy #combinationtherapy #usfda
#ESMO22: Seagen builds case for Padcev-Keytruda combo in front-line bladder cancer - More like this https://t.co/7hAuMooflV | @SeagenGlobal @AstellasUS @Merck #Research #BladderCancer #Padcev #Keytruda #ClinicalTrialData #blcsm #Biotech https://t.co/mkR6H9D0vL
#アステラス製薬株式会社 は、切除不能な局所進行/転移性 #尿路上皮がん に対する一次治療として、抗体薬物複合体（ADC）である #PADCEV＋#キイトルーダ 併用療法の有効性と安全性を評価した第1b/2相EV-103試験のコホートKで良好なトップライン結果が得られたと発表しました。
https://t.co/GYqdzarxlD
Finally! #earlyacces to #Padcev #EnfortumabVedotin is finally open again in 🇫🇷! So important for our #patients with #bladdercancer. Next Step ➡️ Market Access/reimbursement 🤞🏻Maybe 2023..
Great news for our #patients 🇫🇷 but not yet open for acces. Just some more weeks of patience..#fingerscrossed🤞🏻#cancer #enfortumabvedotin #padcev #bladdercancer
PADCEV (enfortumab vedotin) autorisation d’accès précoce octroyée dans l'indication «En monothérapie pour le traitement du #carcinome urothélial localement avancé ou métastatique ayant reçu précédemment une #chimiothérapie à base de sels de platine..»
👉 https://t.co/7ZEONjDWhT
Last Seen Hashtags on Sotwe
Femdom
Seen from Switzerland
riyadhladyboy
Seen from Switzerland
teenagee https,
Seen from Mexico
คู่ดูดี
Seen from Thailand
momson filter:videos
Seen from India
รังสิต
Seen from Indonesia
monkeyappwinsfull
Seen from Belgium
türkifşa
Seen from Netherlands
KeitaroNagame
Seen from Vietnam
tanjirokamado yaoi
Seen from Mexico
Trends for you
Most Popular Users
Elon Musk 
@elonmusk
241.2M followers
Barack Obama
@barackobama
119.1M followers
Cristiano Ronaldo
@cristiano
112.6M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.1M followers
Rihanna
@rihanna
98.2M followers
NASA
@nasa
92.2M followers
Justin Bieber
@justinbieber
91.4M followers
KATY PERRY
@katyperry
88.9M followers
Taylor Swift
@taylorswift13
82.8M followers
Lady Gaga
@ladygaga
74.2M followers
Virat Kohli
@imvkohli
71.7M followers
Kim Kardashian
@kimkardashian
70.4M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
64.6M followers
Bill Gates
@billgates
64.5M followers
The Ellen Show
@theellenshow
62.4M followers
Selena Gomez
@selenagomez
61.9M followers
CNN
@cnn
61.8M followers
X
@x
60.8M followers